These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7684714

  • 1. [Long-term results of treatment of chronic active hepatitis B with vidarabine monophosphate].
    Causse X, Guérou V, Rougier P, Trépo C.
    Gastroenterol Clin Biol; 1993; 17(2):144-5. PubMed ID: 7684714
    [No Abstract] [Full Text] [Related]

  • 2. [Antiviral treatment of chronic hepatitis].
    Müller R.
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of adenine arabinoside 5'-monophosphate in kidney recipients with chronic active hepatitis B: a pilot study.
    Pol S, Saltiel C, Legendre C, Carnot F, Driss F, Berthelot P, Bréchot C, Ruet C, Kreis H.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1446-9. PubMed ID: 7680158
    [No Abstract] [Full Text] [Related]

  • 4. [Vidarabine phosphate in the treatment of active chronic hepatitis B. A confirmed hope].
    Ouzan D.
    Rev Prat; 1992 Jun 01; 42(11):1383-6. PubMed ID: 1382310
    [No Abstract] [Full Text] [Related]

  • 5. [Efficacy of adenine arabinoside (vidarabine) in the treatment of periarteritis nodosa associated with chronic active viral hepatitis B].
    Le Quellec A, Bories P, Bauret P, Piera S, Ouzan D, Trepo C, Michel H.
    Gastroenterol Clin Biol; 1986 Oct 01; 10(10):687-8. PubMed ID: 2878855
    [No Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.
    Perrillo RP, Regenstein FG, Bodicky CJ, Campbell CR, Sanders GE, Sunwoo YC.
    Gastroenterology; 1985 Mar 01; 88(3):780-6. PubMed ID: 2578421
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy with ARA-AMP and interferon of chronic active hepatitis B. Interim analysis of an ongoing study.
    Trépo C, Rougier P, Bizollon T, Poupon R, Zarski JP, Quinton A, Miguet JP, Causse X, Chossegros P, Chevallier M.
    J Hepatol; 1991 Mar 01; 13 Suppl 1():S3. PubMed ID: 1720439
    [No Abstract] [Full Text] [Related]

  • 8. Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.
    Hoofnagle JH.
    J Hepatol; 1986 Mar 01; 3 Suppl 2():S73-80. PubMed ID: 2439579
    [Abstract] [Full Text] [Related]

  • 9. The use of corticosteroids in conjunction with antiviral therapy in chronic hepatitis B with ongoing viral replication.
    Perrillo RP.
    J Hepatol; 1986 Mar 01; 3 Suppl 2():S57-64. PubMed ID: 2439577
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin.
    Fiume L, Cerenzia MR, Bonino F, Busi C, Mattioli A, Brunetto MR, Chiaberge E, Verme G.
    Lancet; 1988 Jul 02; 2(8601):13-5. PubMed ID: 2455204
    [Abstract] [Full Text] [Related]

  • 11. Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients.
    Marcellin P, Ouzan D, Degos F, Brechot C, Metman EH, Degott C, Chevalier M, Berthelot P, Trepo C, Benhamou JP.
    Hepatology; 1989 Sep 02; 10(3):328-31. PubMed ID: 2474480
    [Abstract] [Full Text] [Related]

  • 12. [Drug therapy of chronic active hepatitis].
    Wegener M, Börsch G, Schmidt G.
    Med Klin (Munich); 1986 Mar 18; 81(6):223-5. PubMed ID: 2431260
    [No Abstract] [Full Text] [Related]

  • 13. [Long-term lamivudine therapy for interferon-alpha- and/or adenine arabinoside monophosphate-resistant chronic hepatitis B infection. Results of a pilot study].
    Tran A, Longo F, Saint-Paul MC, Doglio A, Benzaken S, Rampal P.
    Gastroenterol Clin Biol; 2000 Dec 18; 24(12):1234-5. PubMed ID: 11173740
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of chronic hepatitis caused by hepatitis B virus].
    Ouzan D.
    Rev Prat; 1990 May 11; 40(14):1298-300. PubMed ID: 1694296
    [No Abstract] [Full Text] [Related]

  • 15. Recurrence of hepatitis B in liver transplants treated with antiviral therapy.
    Marzano A, Debernardi-Venon W, Smedile A, Brunetto MR, Torrani Cerenzia MR, Actis GC, Zamboni F, Ghisetti V, Piantino P, David E, Salizzoni M, Rizzetto M.
    Ital J Gastroenterol Hepatol; 1998 Feb 11; 30(1):77-81. PubMed ID: 9615271
    [Abstract] [Full Text] [Related]

  • 16. Acute delta hepatitis during treatment with adenosine arabinoside monophosphate with resolution of the HBsAg carrier state.
    Garcia G, Smedile A, Bergmann KF, Gerin JL, Gregory PB, Merigan TC, Robinson WS.
    West J Med; 1990 Jul 11; 153(1):80-2. PubMed ID: 1697132
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of chronic hepatitis B].
    Carreño V, Montaño L, Torres M.
    Rev Clin Esp; 1983 Oct 15; 171(1):73-6. PubMed ID: 6197728
    [No Abstract] [Full Text] [Related]

  • 18. [Results of the treatment of chronic active hepatitis with thymus extract (TFX-Polfa). (Evaluation of the preliminary stage of clinical studies)].
    Kiczka W, Juszczyk J, Adamek J.
    Pol Tyg Lek; 1987 Feb 16; 42(7):192-6. PubMed ID: 3299322
    [No Abstract] [Full Text] [Related]

  • 19. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
    Buti M, Jardi R, Rodriguez-Frias F, Allende H, Cotrina M, Esteban R, Guardia J.
    J Med Virol; 1996 Aug 16; 49(4):325-8. PubMed ID: 8877766
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis B-associated membranous glomerulonephritis treated with adenine arabinoside monophosphate.
    Esteban R, Buti M, Vallés M, Allende H, Guardia J.
    Hepatology; 1986 Aug 16; 6(4):762-3. PubMed ID: 2426174
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.